Get a quote

Get a free quote now.

Thank you! Your message has been received!
Oops! Something went wrong while submitting the form.

Personalized dosing in tuberculosis

January 24, 2019

Researchers at Radboud University Medical Center this week published results from a study in 130 patients in which they evaluated the performance of a model-based precision dosing approach (as implemented using the InsightRX Nova platform) versus current standard-of-care (a 3-sample linear-regression approach). The analysis showed that the model-based approach could achieve similar performance with less TDM samples, while also offering more flexibility in sampling times, thereby rendering the approach both a financial and a logistical improvement.

Link to study.

Recent news